Alessandra Pereira Pires
Federal University of São Paulo
Virtual reality as a tool for controlling Aedes aegypti breeding sites
About the Infectious Diseases and Antimicrobial Resistance Session
This session addresses the prevention, surveillance and control of infectious diseases affecting communities worldwide. It covers emerging and re-emerging infections, transmission patterns, outbreak response, antimicrobial resistance, stewardship, diagnostic approaches and public-health strategies designed to reduce communicable disease burden.
Abstract Scope and Participation
Submissions may include studies on bacterial, viral, fungal, parasitic, vector-borne and neglected diseases, as well as antimicrobial use and resistance. Researchers, clinicians, microbiologists, epidemiologists, infection-control teams, pharmacists, public-health practitioners and policymakers may present original research, surveillance reports, interventions, reviews and outbreak experiences.
Topics Covered in Infectious Diseases and Antimicrobial Resistance
Topic 01
Communicable disease prevention and control
Topic 02
Emerging and re-emerging infections
Topic 03
Antimicrobial resistance and stewardship
Topic 04
Outbreak investigation and response
Topic 05
Vector-borne and neglected infectious diseases
Topic 06
Infection surveillance, diagnosis and treatment strategies
Featured Speakers — Infectious Diseases and Antimicrobial Resistance 2027
Mariam Nambuya
Uganda National Institute of Public Health
Thang Nguyen Tien
University of Texas Medical Branch at Galveston
Respiratory virus detections among children hospitalized with pneumonia, Ulaanbaatar, Mongolia
Recent Research Presented at Infectious Diseases and Antimicrobial Resistance Sessions
Cross-border healthcare-seeking behavior among Bundibugyo Ebola virus disease cases during the Uganda outbreak, May to June 2026
Background: Cross-border population mobility can complicate case detection and outbreak control when persons with severe infectious illness seek care across national borders. During Uganda’s 2026…
Tobacco, alcohol use and self-reported tuberculosis in India: Evidence from NFHS-5
Background: Tuberculosis (TB) remains a major public health challenge in India, with persistent socio-economic inequalities influencing exposure and vulnerability. This study examined the association…
Foodborne disease outbreak in a primary school for girls—Saudi Arabia, Riyadh, in 2023: A retrospective cohort study
Background: Foodborne illnesses are infectious or toxic caused by organisms or chemical substances through eating contaminated food. The current outbreak of foodborne diseases occurred in a girls'…
Respiratory virus detections among children hospitalized with pneumonia, Ulaanbaatar, Mongolia
Surveillance for novel respiratory viruses is critical for pandemic preparedness. Children are particularly susceptible to respiratory viral infections. We conducted a cross-sectional study among…
Incidence rate and predictors of aids occurrence among adults living with HIV at a national tertiary referral hospital in Oman, 1992–2024: An ambidirectional cohort study
Background: Despite advances in human immunodeficiency virus (HIV) care globally, HIV remains a major public health challenge, particularly in the Middle East and North Africa (MENA) region. Although…
AI-driven real-time surveillance for infectious disease detection and response in resource-limited settings: Lessons from Kenya
Background: Infectious disease outbreaks continue to pose significant public health challenges globally, particularly in low- and middle-income countries where surveillance systems are often…
Related Scientific Sessions at IPHC 2027
Why Attend the Infectious Diseases and Antimicrobial Resistance Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Infectious Diseases and Antimicrobial Resistance work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Infectious Diseases and Antimicrobial Resistance research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Infectious Diseases and Antimicrobial Resistance track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Infectious Diseases and Antimicrobial Resistance Conference 2027 — FAQs
What is the Infectious Diseases and Antimicrobial Resistance track at IPHC 2027?
The Infectious Diseases and Antimicrobial Resistance track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Infectious Diseases and Antimicrobial Resistance. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Infectious Diseases and Antimicrobial Resistance sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Infectious Diseases and Antimicrobial Resistance are all welcome — whether presenting or attending.
Can I present my research in the Infectious Diseases and Antimicrobial Resistance track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Infectious Diseases and Antimicrobial Resistance sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Infectious Diseases and Antimicrobial Resistance track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.